DM

Doug Mohr

North America, California, United States, Palo Alto

Description

Doug Mohr is a Managing Director and head of the Engine Department at Sutter Hill Ventures where he's involved in creating, building and fin...

Investor Profile

Doug Mohr has made 2 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Seed (50%)
  • Series A (50%)

Country Focus

  • United States (100%)

Industry Focus

  • Medical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Doug Mohr frequently co-invest with?

Playground Global
North America, California, United States, Palo Alto
Co-Investments: 1
Not Boring
North America, New York, United States, New York
Co-Investments: 1
8VC
North America, California, United States, San Francisco
Co-Investments: 2
Factory
North America, California, United States, Menlo Park
Co-Investments: 2
AIX Ventures
North America, California, United States, San Francisco
Co-Investments: 1
AME Cloud Ventures
North America, California, United States, Palo Alto
Co-Investments: 2
Co-Investments: 1
Greylock
North America, California, United States, Menlo Park
Co-Investments: 2

Which angels does Doug Mohr often collaborate with?

NF
North America, California, United States, San Francisco
Shared Deals: 1
PD
North America, California, United States
Shared Deals: 1
NK
North America, California, United States, Portola Valley
Shared Deals: 1
CS
North America, California, United States, Menlo Park
Shared Deals: 1
DE
North America, California, United States
Shared Deals: 1

What are some of recent deals done by Doug Mohr?

Atomic AI

South San Francisco, California, United States

Atomic AI is a developing the cutting-edge fusion of machine learning and structural biology to unlock RNA drug discovery.

Medical
Series AJan 25, 2023
Amount Raised: $35,000,000
Atomic AI

South San Francisco, California, United States

Atomic AI is a developing the cutting-edge fusion of machine learning and structural biology to unlock RNA drug discovery.

Medical
SeedJan 1, 2021
Amount Raised: $7,000,000